Clinical Leader Webinar

  1. Addressing Opportunities And Challenges In Digital Health Data 10/22/2024

    Experts from diverse industry sectors unpack key points from the FDA’s final guidance on Digital Health Technologies (DHT) for remote data collection in clinical investigations.

  2. Driving Product Launch Success In Europe 10/21/2024

    Explore key steps for preparing your medicinal product for the European market, including insights on challenges, timelines, and a success story.

  3. Harnessing The Power Of AI In Health Evidence Generation Strategy 10/21/2024

    Explore applications and limitations for artificial intelligence (AI) in healthcare as decision-makers determine whether to adopt the software in their environments.

  4. Maximize Control And Transparency On The Path To Study Go-Live 10/10/2024

    Simplify the historically complicated, black-box processes around eCOA solution deployment, content storage and visualization, and global go-live.

  5. The Role Data Quality Plays In Getting Your Product To Market 10/9/2024

    Discover how maintaining strong data integrity can transform your clinical trials and strategies you can use to optimize trial builds and streamline data collection processes, ultimately leading to faster approvals.

  6. From Crisis To Confidence: Ensuring Smooth Regulatory Submissions 10/8/2024

    Explore some of the major challenges that medical writing submission specialists face today and strategies that can consistently set the stage for success.

  7. The Golden Era Of GLP-1 Drugs 10/8/2024

    As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

  8. FDA's Vision On PRO Collection For RWE 9/24/2024

    In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies, particularly in light of FDA expectations.

  9. Applying RWD: Use Cases And FDA Guidance 9/17/2024

    This presentation delves into pragmatic approaches for clinical evidence generation and regulatory acceptance. It examines recent FDA draft guidance on integrating RWD/RWE in medical device studies.

  10. Measure Critical Health Outcomes In GLP-1 And Related Obesity Treatments 9/17/2024

    In this session of Digital Health Monthly, Dr. Glenn Gaesser shares his extensive research on the intersection of obesity and exercise physiology, emphasizing the importance of physical activity.